<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27403033</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System Involvement.</ArticleTitle><Pagination><StartPage>4025167</StartPage><MedlinePgn>4025167</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4025167</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/4025167</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major pathogen for severe hand, foot, and mouth disease (HFMD), which leads to severe neurological complications and has high morbidity and mortality. Reliable biomarker for the prediction of deterioration in EV71-infected children with central nervous system (CNS) involvement may reduce the cardiopulmonary failure and mortality. Here, we found that serum IL-27 levels were significantly higher in stage III EV71-infected HFMD patients with early cardiopulmonary failure and strong correlation with CRP levels. IL27p28 polymorphisms (rs153109, rs17855750, and rs181206) did not influence IL-27 production, and these three SNPs were not associated with EV71 infection risk and clinical stage. IL-27 can be used as an prediction indicator for early cardiopulmonary failure in EV71-infected children with CNS involvement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Mingyuan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangzhou Nansha Center for Disease Control and Prevention, Guangzhou 511458, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Longbin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Weiqing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Guangzhou Nansha Central Hospital, Guangzhou 511458, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Weiquan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhulin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Qiling</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Xingwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhizhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Guangzhou Nansha Center for Disease Control and Prevention, Guangzhou 511458, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Keyuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Jincheng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7713-5080</Identifier><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007378">Interleukins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C464565">MYDGF protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002493" MajorTopicYN="N">Central Nervous System Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007378" MajorTopicYN="N">Interleukins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27403033</ArticleId><ArticleId IdType="pmc">PMC4925946</ArticleId><ArticleId IdType="doi">10.1155/2016/4025167</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang P.-N., Shih S.-R. Update on enterovirus 71 infection. Current Opinion in Virology. 2014;5(1):98&#x2013;104. doi: 10.1016/j.coviro.2014.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.-M., Liu C.-C. Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine. Expert Review of Anti-Infective Therapy. 2014;12(4):447&#x2013;456. doi: 10.1586/14787210.2014.895666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2014.895666</ArticleId><ArticleId IdType="pubmed">24579906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma N. Hand, foot, and mouth disease: current scenario and Indian perspective. Indian Journal of Dermatology, Venereology and Leprology. 2013;79(2):165&#x2013;175. doi: 10.4103/0378-6323.107631.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0378-6323.107631</ArticleId><ArticleId IdType="pubmed">23442455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.-C., Kao C.-M., Ling P., Su I.-J., Chang T.-M., Chen S.-H. CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads. Clinical and Developmental Immunology. 2012;2012:9. doi: 10.1155/2012/580696.580696</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/580696</ArticleId><ArticleId IdType="pmc">PMC3486008</ArticleId><ArticleId IdType="pubmed">23133489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi C., Sun Q., Wang S., et al. Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells. Virus Research. 2013;176(1-2):53&#x2013;60. doi: 10.1016/j.virusres.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.05.002</ArticleId><ArticleId IdType="pubmed">23685430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Li R., Xie Z., Huang G., Yuan Q., Zeng J. IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection. International Journal of Clinical and Experimental Medicine. 2014;7(9):2718&#x2013;2723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4211780</ArticleId><ArticleId IdType="pubmed">25356130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Liu H., Wang L., et al. Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PLoS ONE. 2013;8(6) doi: 10.1371/journal.pone.0067430.e67430</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067430</ArticleId><ArticleId IdType="pmc">PMC3696071</ArticleId><ArticleId IdType="pubmed">23840697</ArticleId></ArticleIdList></Reference><Reference><Citation>Stumhofer J. S., Tait E. D., Quinn W. J., III, et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nature Immunology. 2010;11(12):1119&#x2013;1126. doi: 10.1038/ni.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1957</ArticleId><ArticleId IdType="pmc">PMC3059498</ArticleId><ArticleId IdType="pubmed">21057510</ArticleId></ArticleIdList></Reference><Reference><Citation>de Aquino M. T. P., Kapil P., Hinton D. R., et al. IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination. The Journal of Immunology. 2014;193(1):285&#x2013;294. doi: 10.4049/jimmunol.1400058.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400058</ArticleId><ArticleId IdType="pmc">PMC4067872</ArticleId><ArticleId IdType="pubmed">24890725</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Zhang R., Zhang W., et al. IL-27, a cytokine, and IFN-&#x3bb;1, a type III IFN, are coordinated to regulate virus replication through type I IFN. The Journal of Immunology. 2014;192(2):691&#x2013;703. doi: 10.4049/jimmunol.1300252.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300252</ArticleId><ArticleId IdType="pubmed">24337382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q., Swaminathan S., Yang D., et al. Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type i interferon-independent pathway. PLoS ONE. 2013;8(3) doi: 10.1371/journal.pone.0059194.e59194</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059194</ArticleId><ArticleId IdType="pmc">PMC3604098</ArticleId><ArticleId IdType="pubmed">23527130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Zhang Y., Xue F., Xu J., Fang Z. Interleukin-27 rs153109 polymorphism and the risk for immune thrombocytopenia. Autoimmunity. 2013;46(8):509&#x2013;512. doi: 10.3109/08916934.2013.822072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2013.822072</ArticleId><ArticleId IdType="pubmed">23937109</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Ma M., Yang Y., et al. Association between polymorphisms in IL27 and risk for CHD in a Chinese population. Cardiology in the Young. 2016;26(2):237&#x2013;243. doi: 10.1017/s1047951115000037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1047951115000037</ArticleId><ArticleId IdType="pubmed">25662568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Wang L., Fan R., Zhou J., Zhong J. Association of IL-27 gene three polymorphisms with Crohn's disease susceptibility in a Chinese Han population. International Journal of Clinical and Experimental Pathology. 2014;7(12):8952&#x2013;8957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313976</ArticleId><ArticleId IdType="pubmed">25674271</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Yuan X.-D., Hu D., et al. Association between Interleukin-27 gene polymorphisms and susceptibility to allergic rhinitis. Human Immunology. 2014;75(9):991&#x2013;995. doi: 10.1016/j.humimm.2014.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2014.07.004</ArticleId><ArticleId IdType="pubmed">25075448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Zhang P., Tang T., et al. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer. BMC Cancer. 2015;15(1, article 433) doi: 10.1186/s12885-015-1459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-015-1459-7</ArticleId><ArticleId IdType="pmc">PMC4445811</ArticleId><ArticleId IdType="pubmed">26014498</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Zhou B., Wu Y., et al. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics. 2014;66(2):85&#x2013;92. doi: 10.1007/s00251-013-0753-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-013-0753-2</ArticleId><ArticleId IdType="pubmed">24352695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y.-P., Wang W.-L., Li S.-Y., et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12R&#x3b2;1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. Journal of Cancer Research and Clinical Oncology. 2012;138(11):1891&#x2013;1900. doi: 10.1007/s00432-012-1269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-012-1269-0</ArticleId><ArticleId IdType="pubmed">22740240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J.-C., Xiang W.-Y., Lin D.-Z., et al. Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis. International Journal of Clinical and Experimental Pathology. 2015;8(2):1341&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4396284</ArticleId><ArticleId IdType="pubmed">25973018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J.-C., Lin D.-Z., Yi L.-L., et al. BTLA exhibits immune memory for alphabeta T cells in patients with active pulmonary tuberculosis. American Journal of Translational Research. 2014;6(5):494&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212924</ArticleId><ArticleId IdType="pubmed">25360214</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J.-C., Zhang Z., Li T.-Y., et al. Assessing the role of IL-35 in colorectal cancer progression and prognosis. International Journal of Clinical and Experimental Pathology. 2013;6(9):1806&#x2013;1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759487</ArticleId><ArticleId IdType="pubmed">24040445</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhu R., Qian Y., Deng J. The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand foot and mouth disease in China: a systematic review. PLoS ONE. 2012;7(1) doi: 10.1371/journal.pone.0029003.e29003</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029003</ArticleId><ArticleId IdType="pmc">PMC3250408</ArticleId><ArticleId IdType="pubmed">22235257</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.-A., Chen Z.-B., Lv T.-G., Han Z.-L. Genetic polymorphism of CCL2-2518, CXCL10-201, IL8+781 and susceptibility to severity of Enterovirus-71 infection in a Chinese population. Inflammation Research. 2014;63(7):549&#x2013;556. doi: 10.1007/s00011-014-0724-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0724-6</ArticleId><ArticleId IdType="pubmed">24609754</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Liu J.-Q., Talebian F., Wu L.-C., Li S., Bai X.-F. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. European Journal of Immunology. 2013;43(2):468&#x2013;479. doi: 10.1002/eji.201242930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242930</ArticleId><ArticleId IdType="pmc">PMC3625660</ArticleId><ArticleId IdType="pubmed">23225163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider R., Yaneva T., Beauseigle D., El-Khoury L., Arbour N. IL-27 increases the proliferation and effector functions of human na&#xef;ve CD8+ T lymphocytes and promotes their development into Tc1 cells. European Journal of Immunology. 2011;41(1):47&#x2013;59. doi: 10.1002/eji.201040804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040804</ArticleId><ArticleId IdType="pubmed">21182076</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishima N., Owaki T., Asakawa M., Kamiya S., Mizuguchi J., Yoshimoto T. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. The Journal of Immunology. 2005;175(3):1686&#x2013;1693. doi: 10.4049/jimmunol.175.3.1686.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.3.1686</ArticleId><ArticleId IdType="pubmed">16034109</ArticleId></ArticleIdList></Reference><Reference><Citation>Do J., Visperas A., Sanogo Y. O., et al. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell&#x2013;suppressive function and therapeutic efficacy. Mucosal Immunology. 2015;9(1):137&#x2013;145. doi: 10.1038/mi.2015.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.45</ArticleId><ArticleId IdType="pmc">PMC4662649</ArticleId><ArticleId IdType="pubmed">26013006</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M.-S., Liu Z., Liu J.-Q., Zhu X., Liu Z., Bai X.-F. The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy. Immunotherapy. 2015;7(2):191&#x2013;200. doi: 10.2217/imt.14.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt.14.95</ArticleId><ArticleId IdType="pmc">PMC4356131</ArticleId><ArticleId IdType="pubmed">25713993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Xia S., Sun H., et al. Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells. The Journal of Immunology. 2013;191(1):500&#x2013;508. doi: 10.4049/jimmunol.1300328.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300328</ArticleId><ArticleId IdType="pubmed">23733881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirahara K., Ghoreschi K., Yang X.-P., et al. Interleukin-27 priming of T cells controls il-17 production in trans via induction of the ligand PD-L1. Immunity. 2012;36(6):1017&#x2013;1030. doi: 10.1016/j.immuni.2012.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.024</ArticleId><ArticleId IdType="pmc">PMC3785111</ArticleId><ArticleId IdType="pubmed">22726954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascanfroni I. D., Yeste A., Vieira S. M., et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nature Immunology. 2013;14(10):1054&#x2013;1063. doi: 10.1038/ni.2695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2695</ArticleId><ArticleId IdType="pmc">PMC3964005</ArticleId><ArticleId IdType="pubmed">23995234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Qiu J.-H., Wang T., et al. Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia. Blood. 2014;124(22):3316&#x2013;3319. doi: 10.1182/blood-2014-06-580084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-06-580084</ArticleId><ArticleId IdType="pmc">PMC4239337</ArticleId><ArticleId IdType="pubmed">25298039</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F. W., Ewbank J., Howes A., et al. Type I IFN induces IL-10 production in an IL-27&#x2014;independent manner and blocks responsiveness to IFN-&#x3b3; for production of IL-12 and bacterial killing in Mycobacterium tuberculosis&#x2014;infected macrophages. The Journal of Immunology. 2014;193(7):3600&#x2013;3612. doi: 10.4049/jimmunol.1401088.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401088</ArticleId><ArticleId IdType="pmc">PMC4170673</ArticleId><ArticleId IdType="pubmed">25187652</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank A. C., Zhang X., Katsounas A., Bharucha J. P., Kottilil S., Imamichi T. Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. Journal of Interferon and Cytokine Research. 2010;30(6):427&#x2013;431. doi: 10.1089/jir.2009.0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2009.0093</ArticleId><ArticleId IdType="pmc">PMC2964364</ArticleId><ArticleId IdType="pubmed">20235668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong W. P., Horai R., Mattapallil M. J., et al. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses. Journal of Autoimmunity. 2014;50:12&#x2013;22. doi: 10.1016/j.jaut.2013.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2013.08.003</ArticleId><ArticleId IdType="pmc">PMC3975693</ArticleId><ArticleId IdType="pubmed">24021664</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae S.-C., Li C.-S., Kim K. M., et al. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. Journal of Human Genetics. 2007;52(4):355&#x2013;361. doi: 10.1007/s10038-007-0123-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10038-007-0123-8</ArticleId><ArticleId IdType="pubmed">17318299</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N., Liu L., Wang X.-Z., Liu D., Yin S.-Y., Yang X.-D. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA and Cell Biology. 2008;27(9):527&#x2013;531. doi: 10.1089/dna.2007.0715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2007.0715</ArticleId><ArticleId IdType="pubmed">18554158</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Gorycka A., Raszkiewicz B., Jurkowska M., et al. Association of single nucleotide polymorphisms in the IL27 gene with rheumatoid arthritis. Scandinavian Journal of Immunology. 2014;80(4):298&#x2013;305. doi: 10.1111/sji.12209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12209</ArticleId><ArticleId IdType="pubmed">25041531</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C.-S., Zhang Q., Lee K.-J., et al. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. Journal of Gastroenterology and Hepatology (Australia) 2009;24(10):1692&#x2013;1696. doi: 10.1111/j.1440-1746.2009.05901.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2009.05901.x</ArticleId><ArticleId IdType="pubmed">19686419</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J. Y., Sim J. K., Jung W. J., et al. Association between interleukin-27 polymorphisms and pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease. 2015;19(6):702&#x2013;708. doi: 10.5588/ijtld.14.0773.</Citation><ArticleIdList><ArticleId IdType="doi">10.5588/ijtld.14.0773</ArticleId><ArticleId IdType="pubmed">25946363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zicca E., Quirino A., Marascio N., et al. Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy? BMC Infectious Diseases. 2014;14(supplement 5, article S5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160899</ArticleId><ArticleId IdType="pubmed">25236666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y.-S., Lan Y., Luo B., Lu D., Nong H.-B. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Molecular Carcinogenesis. 2009;48(8):751&#x2013;757. doi: 10.1002/mc.20522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mc.20522</ArticleId><ArticleId IdType="pubmed">19148899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Gao X., Wang Y., Jia J., Zhang Q., Ji Z. Interleukin 27 -964A &gt; G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer. Tumor Biology. 2015;36(10):8207&#x2013;8211. doi: 10.1007/s13277-015-3570-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-3570-4</ArticleId><ArticleId IdType="pubmed">25994572</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y.-J., Wang J.-L., Nong L.-G., Lan C.-G., Zha Z.-G., Liao P.-H. Associations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk. Medicine. 2014;93(10, article e56) doi: 10.1097/md.0000000000000056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000000056</ArticleId><ArticleId IdType="pmc">PMC4616331</ArticleId><ArticleId IdType="pubmed">25170932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>